The stock of Nextcure Inc (NASDAQ: NXTC) has increased by 8.86 when compared to last closing price of 1.58.Despite this, the company has seen a gain of 15.44% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-02 that BELTSVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will present at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11th, at 12:45 pm ET.
Is It Worth Investing in Nextcure Inc (NASDAQ: NXTC) Right Now?
The stock has a 36-month beta value of 0.57. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NXTC is 21.15M, and at present, short sellers hold a 0.54% of that float. On May 10, 2024, the average trading volume of NXTC was 300.59K shares.
NXTC’s Market Performance
The stock of Nextcure Inc (NXTC) has seen a 15.44% increase in the past week, with a -8.99% drop in the past month, and a 32.31% gain in the past quarter. The volatility ratio for the week is 8.65%, and the volatility levels for the past 30 days are at 11.87% for NXTC. The simple moving average for the past 20 days is 12.46% for NXTC’s stock, with a 20.76% simple moving average for the past 200 days.
Analysts’ Opinion of NXTC
Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see NXTC reach a price target of $16. The rating they have provided for NXTC stocks is “Buy” according to the report published on March 01st, 2022.
Truist gave a rating of “Buy” to NXTC, setting the target price at $19 in the report published on March 05th of the previous year.
NXTC Trading at 0.68% from the 50-Day Moving Average
After a stumble in the market that brought NXTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.07% of loss for the given period.
Volatility was left at 11.87%, however, over the last 30 days, the volatility rate increased by 8.65%, as shares sank -8.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.50% upper at present.
During the last 5 trading sessions, NXTC rose by +15.44%, which changed the moving average for the period of 200-days by unch in comparison to the 20-day moving average, which settled at $1.5215. In addition, Nextcure Inc saw 50.88% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NXTC
Current profitability levels for the company are sitting at:
- -10.56 for the present operating margin
- 0.4 for the gross margin
The net margin for Nextcure Inc stands at -10.14. The total capital return value is set at -0.63. Equity return is now at value -50.33, with -45.05 for asset returns.
Based on Nextcure Inc (NXTC), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -59.36. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -68.03.
Currently, EBITDA for the company is -63.95 million with net debt to EBITDA at 0.19. When we switch over and look at the enterprise to sales, we see a ratio of 5.79. The receivables turnover for the company is 10.47for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.70.
Conclusion
To sum up, Nextcure Inc (NXTC) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
